HEADER TRANSCRIPTION 06-JUL-00 1F93 TITLE CRYSTAL STRUCTURE OF A COMPLEX BETWEEN THE DIMERIZATION TITLE 2 DOMAIN OF HNF-1 ALPHA AND THE COACTIVATOR DCOH COMPND MOL_ID: 1; COMPND 2 MOLECULE: DIMERIZATION COFACTOR OF HEPATOCYTE NUCLEAR COMPND 3 FACTOR 1-ALPHA; COMPND 4 CHAIN: A, B, C, D; COMPND 5 SYNONYM: PTERIN-4-ALPHA-CARBINOLAMINE DEHYDRATASE, PHS, COMPND 6 DCOH; COMPND 7 ENGINEERED: YES; COMPND 8 MOL_ID: 2; COMPND 9 MOLECULE: HEPATOCYTE NUCLEAR FACTOR 1-ALPHA; COMPND 10 CHAIN: E, F, G, H; COMPND 11 FRAGMENT: DIMERIZATION DOMAIN (RESIDUES 1-32); COMPND 12 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: RATTUS NORVEGICUS; SOURCE 3 ORGANISM_COMMON: NORWAY RAT; SOURCE 4 ORGANISM_TAXID: 10116; SOURCE 5 ORGAN: LIVER; SOURCE 6 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 7 EXPRESSION_SYSTEM_TAXID: 562; SOURCE 8 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 9 EXPRESSION_SYSTEM_PLASMID: PGEX GST FUSION PLASMID SOURCE 10 (PHARMACIA); SOURCE 11 MOL_ID: 2; SOURCE 12 SYNTHETIC: YES; SOURCE 13 OTHER_DETAILS: THIS PEPTIDE WAS CHEMICALLY SYNTHESIZED. SOURCE 14 THE SEQUENCE OF THIS PEPTIDE NATURALLY OCCURS IN MOUSE SOURCE 15 (MUS MUSCULUS) KEYWDS FOUR-HELIX BUNDLE, TRANSCRIPTIONAL ACTIVATOR/COACTIVATOR KEYWDS 2 COMPLEX, DIMERIZATION DOMAIN EXPDTA X-RAY DIFFRACTION AUTHOR R.B.ROSE,J.H.BAYLE,J.A.ENDRIZZI,J.D.CRONK,G.R.CRABTREE, AUTHOR 2 T.ALBER REVDAT 3 24-FEB-09 1F93 1 VERSN REVDAT 2 01-APR-03 1F93 1 JRNL REVDAT 1 20-SEP-00 1F93 0 JRNL AUTH R.B.ROSE,J.H.BAYLE,J.A.ENDRIZZI,J.D.CRONK, JRNL AUTH 2 G.R.CRABTREE,T.ALBER JRNL TITL STRUCTURAL BASIS OF DIMERIZATION, COACTIVATOR JRNL TITL 2 RECOGNITION AND MODY3 MUTATIONS IN HNF-1ALPHA. JRNL REF NAT.STRUCT.BIOL. V. 7 744 2000 JRNL REFN ISSN 1072-8368 JRNL PMID 10966642 JRNL DOI 10.1038/78966 REMARK 1 REMARK 1 REFERENCE 1 REMARK 1 AUTH J. A.ENDRIZZI,J.D.CRONK,W.WEIDONG,G.R.CRABTREE, REMARK 1 AUTH 2 T.ALBER REMARK 1 TITL CRYSTAL STRUCTURE OF DCOH, A BIFUNCTIONAL, REMARK 1 TITL 2 PROTEIN-BINDING TRANSCRIPTIONAL COACTIVATOR REMARK 1 REF SCIENCE V. 268 556 1995 REMARK 1 REFN ISSN 0036-8075 REMARK 1 REFERENCE 2 REMARK 1 AUTH J.D.CRONK,J.A.ENDRIZZI,T.ALBER REMARK 1 TITL HIGH-RESOLUTION STRUCTURES OF THE BIFUNCTIONAL REMARK 1 TITL 2 ENZYME AND TRANSCRIPTIONAL COACTIVATOR DCOH AND REMARK 1 TITL 3 ITS COMPLEX WITH A PRODUCT ANALOGUE REMARK 1 REF PROTEIN SCI. V. 5 1963 1996 REMARK 1 REFN ISSN 0961-8368 REMARK 2 REMARK 2 RESOLUTION. 2.60 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : CNS 0.4 REMARK 3 AUTHORS : BRUNGER,ADAMS,CLORE,DELANO,GROS,GROSSE- REMARK 3 : KUNSTLEVE,JIANG,KUSZEWSKI,NILGES, PANNU, REMARK 3 : READ,RICE,SIMONSON,WARREN REMARK 3 REMARK 3 REFINEMENT TARGET : ENGH AND HUBER REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.60 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 20.10 REMARK 3 DATA CUTOFF (SIGMA(F)) : 0.000 REMARK 3 DATA CUTOFF HIGH (ABS(F)) : 912032.470 REMARK 3 DATA CUTOFF LOW (ABS(F)) : 0.0000 REMARK 3 COMPLETENESS (WORKING+TEST) (%) : 95.1 REMARK 3 NUMBER OF REFLECTIONS : 16569 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 CROSS-VALIDATION METHOD : THROUGHOUT REMARK 3 FREE R VALUE TEST SET SELECTION : RANDOM REMARK 3 R VALUE (WORKING SET) : 0.257 REMARK 3 FREE R VALUE : 0.299 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 7.800 REMARK 3 FREE R VALUE TEST SET COUNT : 1296 REMARK 3 ESTIMATED ERROR OF FREE R VALUE : 0.008 REMARK 3 REMARK 3 FIT IN THE HIGHEST RESOLUTION BIN. REMARK 3 TOTAL NUMBER OF BINS USED : 6 REMARK 3 BIN RESOLUTION RANGE HIGH (A) : 2.60 REMARK 3 BIN RESOLUTION RANGE LOW (A) : 2.76 REMARK 3 BIN COMPLETENESS (WORKING+TEST) (%) : 99.60 REMARK 3 REFLECTIONS IN BIN (WORKING SET) : 2629 REMARK 3 BIN R VALUE (WORKING SET) : 0.3100 REMARK 3 BIN FREE R VALUE : 0.3710 REMARK 3 BIN FREE R VALUE TEST SET SIZE (%) : 8.00 REMARK 3 BIN FREE R VALUE TEST SET COUNT : 230 REMARK 3 ESTIMATED ERROR OF BIN FREE R VALUE : 0.024 REMARK 3 REMARK 3 NUMBER OF NON-HYDROGEN ATOMS USED IN REFINEMENT. REMARK 3 PROTEIN ATOMS : 4044 REMARK 3 NUCLEIC ACID ATOMS : 0 REMARK 3 HETEROGEN ATOMS : 0 REMARK 3 SOLVENT ATOMS : 62 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 43.30 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 58.70 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -4.32000 REMARK 3 B22 (A**2) : -2.19000 REMARK 3 B33 (A**2) : 6.51000 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : -2.73000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM LUZZATI PLOT (A) : 0.37 REMARK 3 ESD FROM SIGMAA (A) : 0.27 REMARK 3 LOW RESOLUTION CUTOFF (A) : 5.00 REMARK 3 REMARK 3 CROSS-VALIDATED ESTIMATED COORDINATE ERROR. REMARK 3 ESD FROM C-V LUZZATI PLOT (A) : 0.45 REMARK 3 ESD FROM C-V SIGMAA (A) : 0.45 REMARK 3 REMARK 3 RMS DEVIATIONS FROM IDEAL VALUES. REMARK 3 BOND LENGTHS (A) : 0.006 REMARK 3 BOND ANGLES (DEGREES) : 1.10 REMARK 3 DIHEDRAL ANGLES (DEGREES) : 20.20 REMARK 3 IMPROPER ANGLES (DEGREES) : 0.60 REMARK 3 REMARK 3 ISOTROPIC THERMAL MODEL : RESTRAINED REMARK 3 REMARK 3 ISOTROPIC THERMAL FACTOR RESTRAINTS. RMS SIGMA REMARK 3 MAIN-CHAIN BOND (A**2) : 3.460 ; 1.500 REMARK 3 MAIN-CHAIN ANGLE (A**2) : 5.090 ; 2.000 REMARK 3 SIDE-CHAIN BOND (A**2) : 5.220 ; 2.000 REMARK 3 SIDE-CHAIN ANGLE (A**2) : 6.940 ; 2.500 REMARK 3 REMARK 3 BULK SOLVENT MODELING. REMARK 3 METHOD USED : FLAT MODEL REMARK 3 KSOL : 0.36 REMARK 3 BSOL : 55.35 REMARK 3 REMARK 3 NCS MODEL : NULL REMARK 3 REMARK 3 NCS RESTRAINTS. RMS SIGMA/WEIGHT REMARK 3 GROUP 1 POSITIONAL (A) : NULL ; NULL REMARK 3 GROUP 1 B-FACTOR (A**2) : NULL ; NULL REMARK 3 REMARK 3 PARAMETER FILE 1 : PROTEIN_REP.PARAM REMARK 3 PARAMETER FILE 2 : WATER.PARAM REMARK 3 PARAMETER FILE 3 : NULL REMARK 3 TOPOLOGY FILE 1 : PROTEIN.TOP REMARK 3 TOPOLOGY FILE 2 : WATER.TOP REMARK 3 TOPOLOGY FILE 3 : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: USED NON-CRYSTALLOGRAPHIC SYMMETRY REMARK 4 REMARK 4 1F93 COMPLIES WITH FORMAT V. 3.15, 01-DEC-08 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY RCSB ON 17-JUL-00. REMARK 100 THE RCSB ID CODE IS RCSB011394. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 01-JAN-98 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.0 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : Y REMARK 200 RADIATION SOURCE : SSRL REMARK 200 BEAMLINE : BL1-5 REMARK 200 X-RAY GENERATOR MODEL : NULL REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.06880 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : CCD REMARK 200 DETECTOR MANUFACTURER : ADSC QUANTUM REMARK 200 INTENSITY-INTEGRATION SOFTWARE : MOSFLM REMARK 200 DATA SCALING SOFTWARE : CCP4 (SCALA) REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 16500 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.600 REMARK 200 RESOLUTION RANGE LOW (A) : 20.000 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : 2.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 95.0 REMARK 200 DATA REDUNDANCY : 3.600 REMARK 200 R MERGE (I) : 0.06000 REMARK 200 R SYM (I) : NULL REMARK 200 FOR THE DATA SET : 22.0000 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.60 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.67 REMARK 200 COMPLETENESS FOR SHELL (%) : 95.0 REMARK 200 DATA REDUNDANCY IN SHELL : 3.40 REMARK 200 R MERGE FOR SHELL (I) : 0.30000 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 FOR SHELL : NULL REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: NULL REMARK 200 SOFTWARE USED: SHARP REMARK 200 STARTING MODEL: NULL REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 46.61 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.30 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: PEG 8000, POTASSIUM SUCCINATE, PH REMARK 280 5.0, VAPOR DIFFUSION, HANGING DROP, TEMPERATURE 277.0K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 1 21 1 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X,Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 2 0.000000 1.000000 0.000000 41.37500 REMARK 290 SMTRY3 2 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 300 REMARK: THE BIOLOGICAL ASSEMBLY IS A HETEROTETRAMER CONSISTING REMARK 300 OF A DCOH DIMER AND AN HNF-1 ALPHA DIMERIZATION DOMAIN REMARK 300 DIMER. THERE ARE TWO HETEROTETRAMERS IN THE REMARK 300 ASYMMETRIC UNIT. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4950 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12840 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -36.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, E, F REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4840 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 12240 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -37.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: C, D, G, H REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 MSE A 1 REMARK 465 MSE B 1 REMARK 465 ALA B 2 REMARK 465 GLY B 3 REMARK 465 LYS B 4 REMARK 465 THR B 104 REMARK 465 MSE C 1 REMARK 465 ALA C 2 REMARK 465 GLY C 3 REMARK 465 LYS C 4 REMARK 465 ALA C 5 REMARK 465 MSE D 1 REMARK 465 ALA D 2 REMARK 465 GLY D 3 REMARK 465 LYS D 4 REMARK 465 GLU E 32 REMARK 465 MET F 1 REMARK 465 VAL F 2 REMARK 465 SER F 3 REMARK 465 LYS F 4 REMARK 465 GLU F 32 REMARK 465 MET G 1 REMARK 465 VAL G 2 REMARK 465 SER G 3 REMARK 465 GLY G 31 REMARK 465 GLU G 32 REMARK 465 MET H 1 REMARK 465 VAL H 2 REMARK 465 SER H 3 REMARK 465 LYS H 4 REMARK 465 GLY H 31 REMARK 465 GLU H 32 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS(M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 GLN A 15 CG CD OE1 NE2 REMARK 470 LYS A 41 CG CD CE NZ REMARK 470 GLU B 11 CG CD OE1 OE2 REMARK 470 GLN B 15 CG CD OE1 NE2 REMARK 470 ARG B 88 CG CD NE CZ NH1 NH2 REMARK 470 GLN C 15 CG CD OE1 NE2 REMARK 470 LYS C 41 CG CD CE NZ REMARK 470 VAL C 101 CG1 CG2 REMARK 470 GLU D 11 CG CD OE1 OE2 REMARK 470 GLN D 15 CG CD OE1 NE2 REMARK 470 LYS D 36 CG CD CE NZ REMARK 470 LYS D 72 CG CD CE NZ REMARK 470 GLU D 87 CG CD OE1 OE2 REMARK 470 GLN D 98 CG CD OE1 NE2 REMARK 470 LYS G 4 CG CD CE NZ REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 TYR A 70 -102.37 60.54 REMARK 500 SER A 78 149.19 -173.18 REMARK 500 LYS B 36 135.94 -170.53 REMARK 500 TYR B 70 -103.01 58.82 REMARK 500 LEU C 8 106.65 -56.90 REMARK 500 ALA C 10 -30.11 -39.98 REMARK 500 ARG C 31 122.48 178.97 REMARK 500 ASP C 32 89.90 -57.74 REMARK 500 TYR C 70 -102.71 60.18 REMARK 500 SER C 78 -175.30 -174.23 REMARK 500 HIS C 80 108.56 51.59 REMARK 500 GLU C 81 44.71 33.29 REMARK 500 CYS C 82 -64.40 -107.04 REMARK 500 ALA C 83 9.57 -167.13 REMARK 500 HIS D 6 -28.12 65.29 REMARK 500 ARG D 7 146.05 64.41 REMARK 500 LEU D 8 100.41 -49.86 REMARK 500 VAL D 23 -73.59 -51.20 REMARK 500 TYR D 70 -102.49 60.88 REMARK 500 SER D 78 -179.89 178.47 REMARK 500 HIS D 80 -72.54 -46.39 REMARK 500 GLU D 81 49.61 -52.39 REMARK 500 CYS D 82 -19.43 166.66 REMARK 500 GLU D 87 49.94 -71.83 REMARK 500 ARG D 88 -36.60 -158.69 REMARK 500 ALA D 100 -72.90 -48.39 REMARK 500 VAL E 2 -45.62 74.35 REMARK 500 SER E 3 -25.32 61.91 REMARK 500 LEU E 30 25.60 -76.00 REMARK 500 SER G 6 -165.46 -108.53 REMARK 500 REMARK 500 REMARK: NULL DBREF 1F93 A 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 B 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 C 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 D 1 104 UNP P61459 PHS_RAT 1 104 DBREF 1F93 E 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 F 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 G 1 32 UNP P22361 HNF1A_MOUSE 1 32 DBREF 1F93 H 1 32 UNP P22361 HNF1A_MOUSE 1 32 SEQADV 1F93 MSE A 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE A 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE A 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE B 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE B 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE B 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE C 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE C 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE C 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQADV 1F93 MSE D 1 UNP P61459 MET 1 MODIFIED RESIDUE SEQADV 1F93 MSE D 50 UNP P61459 MET 50 MODIFIED RESIDUE SEQADV 1F93 MSE D 103 UNP P61459 MET 103 MODIFIED RESIDUE SEQRES 1 A 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 A 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 A 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 A 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 A 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 A 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 A 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 A 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 B 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 B 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 B 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 B 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 B 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 B 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 B 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 B 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 C 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 C 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 C 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 C 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 C 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 C 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 C 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 C 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 D 104 MSE ALA GLY LYS ALA HIS ARG LEU SER ALA GLU GLU ARG SEQRES 2 D 104 ASP GLN LEU LEU PRO ASN LEU ARG ALA VAL GLY TRP ASN SEQRES 3 D 104 GLU LEU GLU GLY ARG ASP ALA ILE PHE LYS GLN PHE HIS SEQRES 4 D 104 PHE LYS ASP PHE ASN ARG ALA PHE GLY PHE MSE THR ARG SEQRES 5 D 104 VAL ALA LEU GLN ALA GLU LYS LEU ASP HIS HIS PRO GLU SEQRES 6 D 104 TRP PHE ASN VAL TYR ASN LYS VAL HIS ILE THR LEU SER SEQRES 7 D 104 THR HIS GLU CYS ALA GLY LEU SER GLU ARG ASP ILE ASN SEQRES 8 D 104 LEU ALA SER PHE ILE GLU GLN VAL ALA VAL SER MSE THR SEQRES 1 E 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 E 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 E 32 ILE GLN ALA LEU GLY GLU SEQRES 1 F 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 F 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 F 32 ILE GLN ALA LEU GLY GLU SEQRES 1 G 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 G 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 G 32 ILE GLN ALA LEU GLY GLU SEQRES 1 H 32 MET VAL SER LYS LEU SER GLN LEU GLN THR GLU LEU LEU SEQRES 2 H 32 ALA ALA LEU LEU GLU SER GLY LEU SER LYS GLU ALA LEU SEQRES 3 H 32 ILE GLN ALA LEU GLY GLU MODRES 1F93 MSE A 50 MET SELENOMETHIONINE MODRES 1F93 MSE A 103 MET SELENOMETHIONINE MODRES 1F93 MSE B 50 MET SELENOMETHIONINE MODRES 1F93 MSE B 103 MET SELENOMETHIONINE MODRES 1F93 MSE C 50 MET SELENOMETHIONINE MODRES 1F93 MSE C 103 MET SELENOMETHIONINE MODRES 1F93 MSE D 50 MET SELENOMETHIONINE MODRES 1F93 MSE D 103 MET SELENOMETHIONINE HET MSE A 50 8 HET MSE A 103 8 HET MSE B 50 8 HET MSE B 103 8 HET MSE C 50 8 HET MSE C 103 8 HET MSE D 50 8 HET MSE D 103 8 HETNAM MSE SELENOMETHIONINE FORMUL 1 MSE 8(C5 H11 N O2 SE) FORMUL 9 HOH *62(H2 O) HELIX 1 1 SER A 9 VAL A 23 1 15 HELIX 2 2 ASP A 42 ASP A 61 1 20 HELIX 3 3 SER A 86 SER A 102 1 17 HELIX 4 4 SER B 9 VAL B 23 1 15 HELIX 5 5 ASP B 42 ASP B 61 1 20 HELIX 6 6 HIS B 80 ALA B 83 5 4 HELIX 7 7 SER B 86 MSE B 103 1 18 HELIX 8 8 SER C 9 ALA C 22 1 14 HELIX 9 9 ASP C 42 ASP C 61 1 20 HELIX 10 10 SER C 86 SER C 102 1 17 HELIX 11 11 SER D 9 GLY D 24 1 16 HELIX 12 12 ASP D 42 ASP D 61 1 20 HELIX 13 13 ARG D 88 SER D 102 1 15 HELIX 14 14 SER E 6 SER E 19 1 14 HELIX 15 15 SER E 22 LEU E 30 1 9 HELIX 16 16 SER F 6 SER F 19 1 14 HELIX 17 17 SER F 22 LEU F 30 1 9 HELIX 18 18 SER G 6 SER G 19 1 14 HELIX 19 19 SER G 22 LEU G 30 1 9 HELIX 20 20 SER H 6 SER H 19 1 14 HELIX 21 21 SER H 22 LEU H 30 1 9 SHEET 1 A 8 ASN A 26 GLU A 27 0 SHEET 2 A 8 ILE A 34 HIS A 39 -1 N PHE A 35 O ASN A 26 SHEET 3 A 8 LYS A 72 LEU A 77 -1 N VAL A 73 O PHE A 38 SHEET 4 A 8 GLU A 65 VAL A 69 -1 N GLU A 65 O THR A 76 SHEET 5 A 8 GLU B 65 VAL B 69 -1 O TRP B 66 N ASN A 68 SHEET 6 A 8 LYS B 72 LEU B 77 -1 N LYS B 72 O VAL B 69 SHEET 7 A 8 ILE B 34 HIS B 39 -1 O ILE B 34 N LEU B 77 SHEET 8 A 8 ASN B 26 GLU B 27 -1 O ASN B 26 N PHE B 35 SHEET 1 B 8 ASN C 26 GLU C 27 0 SHEET 2 B 8 ILE C 34 HIS C 39 -1 N PHE C 35 O ASN C 26 SHEET 3 B 8 LYS C 72 LEU C 77 -1 N VAL C 73 O PHE C 38 SHEET 4 B 8 GLU C 65 VAL C 69 -1 N GLU C 65 O THR C 76 SHEET 5 B 8 GLU D 65 VAL D 69 -1 O TRP D 66 N ASN C 68 SHEET 6 B 8 ILE D 34 HIS D 39 -1 O ILE D 34 N LEU D 77 SHEET 7 B 8 ASN D 26 GLU D 27 -1 O ASN D 26 N PHE D 35 LINK C PHE A 49 N MSE A 50 1555 1555 1.33 LINK C MSE A 50 N THR A 51 1555 1555 1.33 LINK C SER A 102 N MSE A 103 1555 1555 1.33 LINK C MSE A 103 N THR A 104 1555 1555 1.33 LINK C PHE B 49 N MSE B 50 1555 1555 1.33 LINK C MSE B 50 N THR B 51 1555 1555 1.33 LINK C SER B 102 N MSE B 103 1555 1555 1.33 LINK C PHE C 49 N MSE C 50 1555 1555 1.33 LINK C MSE C 50 N THR C 51 1555 1555 1.33 LINK C SER C 102 N MSE C 103 1555 1555 1.33 LINK C MSE C 103 N THR C 104 1555 1555 1.33 LINK C PHE D 49 N MSE D 50 1555 1555 1.33 LINK C MSE D 50 N THR D 51 1555 1555 1.33 LINK C SER D 102 N MSE D 103 1555 1555 1.33 LINK C MSE D 103 N THR D 104 1555 1555 1.33 CRYST1 49.480 82.750 70.640 90.00 97.83 90.00 P 1 21 1 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.020210 0.000000 0.002779 0.00000 SCALE2 0.000000 0.012085 0.000000 0.00000 SCALE3 0.000000 0.000000 0.014290 0.00000